Recurrent lower motor neuron type facial palsy: An unusual manifestation of SLE

BMJ Case Reports

Volumn , Issue , 2011, Pages

  Gupta, Durgesh Kumar ^a   Atam, Virendra ^a   Chaudhary, S C ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; ELECTROMYOGRAPHY; FACIAL NERVE PARALYSIS; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MOTOR NERVE CONDUCTION; MOTOR NEURON DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECURRENT DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

EID: 79955388275     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.12.2010.3564     Document Type: Article

References (9)

1. Nadeau SE. Neurologic manifestations of connective tissue disease. Neurol Clin 2002;20:151-78, vi.
2. Feinglass EJ, Arnett FC, Dorsch CA, et al. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 1976;55:323-39.
3. Abel T, Gladman DD, Urowitz MB. Neuropsychiatric lupus. J Rheumatol 1980;7:325-33.
4. Johnson RT, Richardson EP. The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) 1968;47:337-69.
5. Blaustein DA, Blaustein SA. Antinuclear antibody negative systemic lupus erythematosus presenting as bilateral facial paralysis. J Rheumatol 1998;25:798-800.
6. Scheinberg L. Polyneuritis in systemic lupus erythematosus; review of the literature and report of a case. N Engl J Med 1956;255:416-21.
7. Bódi I, Váradi P, Pokorny G, et al. Polyneuropathy with endoneurial immune complex deposition as the first manifestation of systemic lupus erythematosus. Acta Neuropathol 1998;96:297-300.
8. Bertsias G, Ioannidis JP, Boletis J, et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 2008;67:195-205.
9. Barile-Fabris L, Ariza-Andraca R, Olguín-Ortega L, et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis 2005;64:620-5.